Aflibercept/bevacizumab/ranibizumabVarious toxicities: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1904卷 / 1期

关键词：

D O I：

10.1007/s40278-022-13956-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：24 / 24

相关论文

共 50 条

[1] Aflibercept/bevacizumab/ranibizumabVarious toxicities: 40 case reports
[J]. Reactions Weekly, 2017, 1648 (1) : 18 - 18
[2] Aflibercept/bevacizumab/ranibizumabVarious toxicities: 10 case reports
[J]. Reactions Weekly, 2019, 1769 (1) : 23 - 23
[3] Aflibercept/bevacizumab/ranibizumabVarious toxicities: 3 case reports
[J]. Reactions Weekly, 2021, 1839 (1) : 21 - 22
[4] Aflibercept/ranibizumabVarious toxicities: case report
[J]. Reactions Weekly, 2023, 1938 (1) : 41 - 41
[5] RanibizumabVarious toxicities: 3 case reports
[J]. Reactions Weekly, 2014, 1532 (1) : 171 - 171
[6] RanibizumabVarious toxicities: 4 case reports
[J]. Reactions Weekly, 2020, 1788 (1) : 201 - 201
[7] Aflibercept/bevacizumab/ranibizumabCataract: 6 case reports
[J]. Reactions Weekly, 2022, 1887 (1) : 30 - 30
[8] Bevacizumab/ranibizumabVarious kidney disorders: 3 case reports
[J]. Reactions Weekly, 2021, 1881 (1) : 52 - 52
[9] Bevacizumab/dexamethasoneVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2020, 1785 (1) : 112 - 112
[10] Bevacizumab/doxorubicinCardiac toxicities: 6 case reports
[J]. Reactions Weekly, 2012, 1405 (1) : 11 - 11

← 1 2 3 4 5 →